Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Study protocol

Protocol of the Inner Mongolian Healthy Aging Study (IMAGINS): a longitudinal cohort study

Authors: Yunfeng Xi, Qiuyue Tian, Buqi Na, Ke Han, Mingrui Duan, Xingguang Zhang, Wenrui Wang, Youxin Wang

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Cardiovascular diseases (CVDs) remain the leading cause of premature mortality and burden of diseases in the world. The Inner Mongolia Autonomous Region is located in northern China, constitute 17.66% individuals with Mongolian, which have unique diet and lifestyles. Therefore, the Inner Mongolian Healthy Aging Study (IMAGINS) was designed to explore risk factors for chronic diseases and evaluate the effectiveness of health management on CVDs in population at high-risk.

Methods

The IMAGINS is an ongoing and prospective cohort study of men and women aged ≥35 years from Inner Mongolian Autonomous Region, northern China. This study performed in investigating risk factors for CVDs, screening and providing health management strategy for high-risk population of CVDs. The IMAGINS began in September 2015 and scheduled to recruiting and follow-up outcome until 2030. For general population, a long-term follow-up will be conducted every 5 years to collect the information above and data on clinical outcomes. For high-risk population, comprehensive health managements were performed and scheduled to follow-up annually. All IMAGINS participants are followed for incident CVDs and death.

Discussion

The IMAGINS is designed to increase understanding how cardiovascular-related risk factors contribute to the development of CVDs and the positive effect of health management strategy for high-risk CVD participants. Key features of this study include (i) a carefully characterized cohort between high risk of CVDs and non-high risk population; (ii) detailed measurement of CVDs risk factors and health management strategies for high risk population; (iii) long-term follow-up of CVDs and death. The IMAGINS represents a good research opportunity to investigate clinical and genetic factors in high-risk population, might providing basis for the prevention and control of non-communicable diseases.
Literature
1.
Collaborators GDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet (London, England). 2020;396(10258):1204–22.CrossRef
2.
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–32.PubMedCrossRef
3.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
4.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet (London, England). 2012;380(9859):2095–128.CrossRef
5.
Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–52.PubMedPubMedCentralCrossRef
6.
Al-Mallah MH, Sakr S, Al-Qunaibet A. Cardiorespiratory fitness and cardiovascular disease prevention: an update. Curr Atheroscler Rep. 2018;20(1):1.PubMedCrossRef
7.
Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, et al. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5(12):e672–81.PubMedCrossRef
8.
Group TWCRCW. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332–45.CrossRef
9.
Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, et al. Future cardiovascular disease in China: markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ Cardiovasc Qual Outcomes. 2010;3(3):243–52.PubMedPubMedCentralCrossRef
10.
Guo W, Du M, Sun D, Zhao N, Hao Z, Wu R, et al. The effect characteristics of temperature on stroke mortality in Inner Mongolia and globally. Int J Biometeorol. 2019;63(2):159–66.PubMedCrossRef
11.
12.
Sachula, Geilebagan, Zhang YY, Zhao H, Khasbagan. Wild edible plants collected and consumed by the locals in Daqinggou, Inner Mongolia, China. J Ethnobiol Ethnomed. 2020;16(1):60.PubMedPubMedCentralCrossRef
13.
Wang X, Liu A, Du M, Wu J, Wang W, Qian Y, et al. Diet quality is associated with reduced risk of hypertension among Inner Mongolia adults in northern China. Public Health Nutr. 2020;23(9):1543–54.PubMedCrossRef
14.
Jia L, Lu H, Wu J, Wang X, Wang W, Du M, et al. Association between diet quality and obesity indicators among the working-age adults in Inner Mongolia, northern China: a cross-sectional study. BMC Public Health. 2020;20(1):1165.PubMedPubMedCentralCrossRef
15.
Dugee O, Khor GL, Lye MS, Luvsannyam L, Janchiv O, Jamyan B, et al. Association of major dietary patterns with obesity risk among Mongolian men and women. Asia Pac J Clin Nutr. 2009;18(3):433–40.PubMed
16.
Zhang S, Tong W, Xu T, Wu B, Zhang Y. Diabetes and impaired fasting glucose in Mongolian population, Inner Mongolia, China. Diabetes Res Clin Pract. 2009;86(2):124–9.PubMedCrossRef
17.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet (London, England). 2019;394(10204):1145–58.CrossRef
18.
Bai Z, Yang X, Han X, Dong P, Liu A. Comparison between coronary plaque 64-slice spiral CT characteristics and risk factors of coronary artery disease patients in Chinese Han population and Mongolian. Pak J Med Sci. 2013;29(4):933–7.PubMedPubMedCentralCrossRef
19.
Komatsu F, Kagawa Y, Kawabata T, Kaneko Y, Purvee B, Otgon J, et al. Dietary habits of Mongolian people, and their influence on lifestyle-related diseases and early aging. Curr Aging Sci. 2008;1(2):84–100.PubMedCrossRef
20.
Zhang C, Lan T, Zhe Y, Hu B, Zhang G, He J, et al. Epidemiology investigation of stroke among Mongolian and Han population aged over 45 in Inner Mongolia. Sci Rep. 2017;7:45710.PubMedPubMedCentralCrossRef
21.
Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16:294.PubMedPubMedCentralCrossRef
22.
Xi Y, Niu L, Cao N, Bao H, Xu X, Zhu H, et al. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in northern China: a cross-sectional study. BMC Public Health. 2020;20(1):1068.PubMedPubMedCentralCrossRef
23.
Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation. 2016;134(19):1430–40.PubMedCrossRef
24.
Tian Q, Wang A, Zuo Y, Chen S, Hou H, Wang W, et al. All-cause mortality in metabolically healthy individuals was not predicted by overweight and obesity. JCI Insight. 2020;5(16):e136982.PubMedCentralCrossRef
25.
Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–66.PubMedPubMedCentralCrossRef
26.
Wang Y, Ge S, Yan Y, Wang A, Zhao Z, Yu X, et al. China suboptimal health cohort study: rationale, design and baseline characteristics. J Transl Med. 2016;14(1):291.PubMedPubMedCentralCrossRef
27.
Wang T, Zhang W, Zhang M, Zhang Y, Zhang S. Higher heart rates increase risk of diabetes and cardiovascular events: a prospective cohort study among inner Mongolians. Diabetes Metab. 2020;46(1):20–6.PubMedCrossRef
28.
Cong L, Ren Y, Hou T, Han X, Dong Y, Wang Y, et al. Use of cardiovascular drugs for primary and secondary prevention of cardiovascular disease among rural-dwelling older Chinese adults. Front Pharmacol. 2020;11:608136.PubMedPubMedCentralCrossRef
29.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE million persons project). Lancet (London, England). 2017;390(10112):2549–58.CrossRef
30.
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125–51.PubMedCrossRef
31.
Liss DT, Uchida T, Wilkes CL, Radakrishnan A, Linder JA. General health checks in adult primary care: a review. Jama. 2021;325(22):2294–306.PubMedCrossRef
32.
Xi Y, Cao N, Niu L, Zhu H, Bao H, Qiao L, et al. Prevalence and treatment of high cardiovascular disease risk in Inner Mongolia, China. Rev Cardiovasc Med. 2021;22(2):521–9.PubMedCrossRef
33.
Xi Y, Bao H, Han K, Qiao L, Xu X, Zhu H, et al. Evaluating the treatment and control of modifiable cardiovascular disease risk factors among patients with diabetes in the Inner Mongolia, China: a cross-sectional study. Prev Med. 2020;139:106174.PubMedCrossRef
34.
Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, et al. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) million persons project pilot. BMJ Open. 2016;6(1):e010200.PubMedPubMedCentralCrossRef
35.
Hendriks EJ, Westerink J, de Jong PA, de Borst GJ, Nathoe HM, Mali WP, et al. Association of high ankle brachial index with incident cardiovascular disease and mortality in a high-risk population. Arterioscler Thromb Vasc Biol. 2016;36(2):412–7.PubMedCrossRef
36.
Alzamora MT, Forés R, Pera G, Torán P, Heras A, Sorribes M, et al. Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort. BMC Cardiovasc Disord. 2013;13:119.PubMedPubMedCentralCrossRef
37.
Lv J, Yu C, Guo Y, Bian Z, Yang L, Chen Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population. J Am Coll Cardiol. 2017;69(9):1116–25.PubMedPubMedCentralCrossRef
38.
Chen C, Lu FC, Department of Disease Control Ministry of Health PRC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.PubMed
39.
World Health Organization. Prevention of cardiovascular disease. Guidelines for assessment and management of cardiovascular risk. Geneva: WHO; 2007.
40.
Liu LS, Writing Group of Chinese Guidelines for the Management of H. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.PubMed
41.
adults JciCgftmodi. 2016 Chinese guideline for the management of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44(10):833–53.
42.
Soroush A, Shams-Alizadeh N, Vahdat A, Mohebi Z, Saeidi M, Komasi S. Role of perceived heart risk factors by outpatient population in predicting cardiovascular risk. J Cardiovasc Thorac Res. 2019;11(2):100–8.PubMedPubMedCentralCrossRef
43.
Li N, Wang H, Yan Z, Yao X, Hong J, Zhou L. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study. BMC Public Health. 2012;12:499.PubMedPubMedCentralCrossRef
44.
Chang PY, Zhao LG, Su XL. Association of TSC gene variants and hypertension in Mongolian and Han populations. Genet Mol Res. 2011;10(2):902–9.PubMedCrossRef
45.
Yang S, Liu S, Wang Y, Wan H, Zhao D, Li Y, et al. High blood pressure in Chinese ethnic minorities: report from rural Yunnan province. Am J Hypertens. 2011;24(11):1209–14.PubMedCrossRef
46.
Kupaev V, Borisov O, Marutina E, Yan YX, Wang W. Integration of suboptimal health status and endothelial dysfunction as a new aspect for risk evaluation of cardiovascular disease. EPMA J. 2016;7(1):19.PubMedPubMedCentralCrossRef
47.
Li Y, Schoufour J, Wang DD, Dhana K, Pan A, Liu X, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ (Clin Res Ed). 2020;368:l6669.
48.
Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ (Clin Res Ed). 2021;373:n604.
49.
Wang K, Li Y, Liu G, Rimm E, Chan AT, Giovannucci EL, et al. Healthy lifestyle for prevention of premature death among users and nonusers of common preventive medications: a prospective study in 2 US cohorts. J Am Heart Assoc. 2020;9(13):e016692.PubMedPubMedCentralCrossRef
50.
Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786–807.PubMedPubMedCentralCrossRef
51.
Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280–7.PubMedPubMedCentralCrossRef
52.
Xu Y, Li H, Wang A, Su Z, Yang G, Luo Y, et al. Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study. Eur J Endocrinol. 2018;179(6):343–52.PubMedCrossRef
53.
Dwivedi AK, Dubey P, Cistola DP, Reddy SY. Association between obesity and cardiovascular outcomes: updated evidence from meta-analysis studies. Curr Cardiol Rep. 2020;22(4):25.PubMedCrossRef
Metadata
Title
Protocol of the Inner Mongolian Healthy Aging Study (IMAGINS): a longitudinal cohort study
Authors
Yunfeng Xi
Qiuyue Tian
Buqi Na
Ke Han
Mingrui Duan
Xingguang Zhang
Wenrui Wang
Youxin Wang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-12542-0

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue

Research

Amplified effect of social vulnerability on health inequality regarding COVID-19 mortality in the USA: the mediating role of vaccination allocation

Research

Minimum acceptable diet intake and its associated factors among children age at 6–23 months in sub-Saharan Africa: a multilevel analysis of the sub-Saharan Africa demographic and health survey

Research

Association between water, sanitation and hygiene (WASH) and child undernutrition in Ethiopia: a hierarchical approach

Research

What is the impact of structural and cultural factors and interventions within educational settings on promoting positive mental health and preventing poor mental health: a systematic review

Research

Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis

Research

Monitoring European data with prospective space–time scan statistics: predicting and evaluating emerging clusters of COVID-19 in European countries